Search

everythinglearnresearchcommunity

for

Search:↓

People with PCOS often have skin problems like excessive hair growth, hair loss, acne, and dark patches, which are linked to hormonal and metabolic imbalances.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

COC treatment improves hormone and metabolic levels in PCOS patients.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Spironolactone treatment increases the amount of testosterone available in the body.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Testosterone therapy increases bone density in older men with low testosterone levels.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Honokiol might help reduce male skin aging by maintaining testosterone levels.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Low testosterone increases kidney stone risk in men not on testosterone therapy.

Segmental hair analysis can track testosterone over time but needs adjustments for sex, hair color, and washing frequency.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Balding and low testosterone increase risk of urinary stones.